Category Archive for: ‘Pain Medication’

A Soldier’s War on Pain

By BARRY MEIER MAY 10, 2014 Four years and a lifetime ago, a new war began for Sgt. Shane Savage. On Sept. 3, 2010, the armored truck he was commanding near Kandahar, Afghanistan, was blown apart by a roadside bomb. His head hit the ceiling so hard that his helmet cracked. His left foot was pinned against the dashboard, crushing 24 …

Read More

F.D.A. Plans New Limits on Painkillers

By GARDINER HARRISPublished: January 13, 2011New York Times WASHINGTON — The government announced Thursday that it would sharply restrict some of the nation’s most popular prescription painkillers, saying they cause many patients to poison themselves with overdoses of the drug acetaminophen. The decision by the Food and Drug Administration fell short of the ban on pills like Percocet and Vicodin …

Read More

Painkiller Prescriptions Jump for Injured Troops

By Gregg ZoroyaUSA TODAYOctober 20, 2008 WASHINGTON — Narcotic pain-relief prescriptions for injured U.S. troops have jumped from 30,000 a month to 50,000 since the Iraq war began, raising concerns about the drugs’ potential abuse and addiction, says a leading Army pain expert. The sharp rise in outpatient prescriptions paid for by the government suggests doctors rely too heavily on …

Read More

Cell Protein Suppresses Pain Better Than Morphine

Injected into mice, it proved more effective but with fewer side effects, study says U.S. News & World ReportOctober 8, 2008 WEDNESDAY, Oct. 8 (HealthDay News) — A cell protein routinely used as a diagnostic for prostate cancer appears to also work as a pain medication that is far more effective than morphine but with far fewer side effects, a …

Read More

‘Abuse-Resistant’ Form of OxyContin May Be Near

09.10.08Forbes.com THURSDAY, Sept. 11 (HealthDay News) — Researchers say they’ve developed an “abuse-resistant” formulation of the widely prescribed opioid pain medication OxyContin. The U.S. Food and Drug Administration has granted Remoxy priority review, meaning that action could come as soon as early December, said Dr. Nadav Friedman, chief operating officer of Pain Therapeutics Inc., which developed Remoxy. If approval is …

Read More